Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Introduction
- Types of OTC Products
- Pharmaceutical OTC Drugs
- Vitamin and Mineral Supplements
- OTC Medical Devices and Diagnostics
- Advantages and Disadvantages of OTC Drugs, Medical Devices, and Diagnostics
- Cost Savings Analysis
- PESTLE Analysis
- Porter’s Five Forces Analysis
- Bargaining Power of Buyers: High
- Bargaining Power of Suppliers: Moderate
- Potential of New Entrants to the Market: Moderate
- Competition in the Industry: High
- Threat of Substitutes: Moderate to High
- Regulatory Landscape
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Growing Prevalence of Chronic Diseases and Expanding Geriatric Populations
- Increasing Health Awareness
- Growing Online Sales Channels and Telehealth Platforms
- Market Restraints
- Presence of Alternative Methods
- Market Opportunities
- Emerging Economies
- Market Challenges
- Misuse and Interactions of OTC Drugs and Medical Devices
- Data Privacy and Security Concerns
Chapter 4 Emerging Technologies and Developments
- Emerging Technologies
- Advanced Drug Delivery
- Advanced Wearable Sensors
- Artificial Intelligence
- Clinical Trials Analysis
- Clinical Trials Analysis by Type of Study
- Clinical Trials Analysis, by Status
- Clinical Trials Analysis, by Phase
Chapter 5 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis by Product
- OTC Drugs
- Pharmaceutical Drugs
- Vitamin and Mineral Supplements
- OTC Devices and Diagnostics
- Monitoring Devices
- Therapeutic Devices
- Diagnostic Devices and Kits
- Market Breakdown by Application
- Respiratory Disorders
- Gastrointestinal Disorders
- Orthopedic Diseases
- Cardiovascular Diseases
- Diabetes
- Skin Disorders
- Obesity
- ENT Disorders
- Sleep Disorders
- Other Disorders
- Geographic Breakdown
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 6 Competitive Intelligence
- Market Analysis
- Strategic Analysis
Chapter 7 Sustainability in OTC Drug, Medical Device, and Diagnostics: An ESG Perspective
- Introduction to ESG
- Sustainability in OTC Drug, Medical Device, and Diagnostics: An ESG Perspective
- Key ESG Issues
- OTC Drug, Medical Device, and Diagnostics ESG Performance Analysis
- Concluding Remarks
List of Tables
Summary Table: Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Product, Through 2029
Table 1: Difference between Prescription v/s OTC Pharmaceutical Drugs
Table 2: Top OTC Pharmaceutical Drugs in Major Categories
Table 3: Top Vitamin and Mineral Supplements in Major Categories
Table 4: Top OTC Medical Devices and Diagnostics in Major Categories
Table 5: FDA Medical Device Classification
Table 6: EU MDR Medical Device Classification
Table 7: Asia-Pacific: Regulatory Landscape
Table 8: RoW: Regulatory Landscape
Table 9: Global: Leading causes of Disease Burden, 2022 v/s 2050
Table 10: U.S.: Sufferers Using Only OTC Products, 2019
Table 11: Comparison of FDA-Cleared Health Monitoring Watches
Table 12: OTC Drugs: Adverse Effects
Table 13: OTC Drug Interaction with Disorders
Table 14: Clinical Trials in OTC Drugs, Medical Devices, and Diagnostics, by Type of Study, October 2024
Table 15: Clinical Trials in OTC Drugs, Medical Devices, and Diagnostics, by Status, October 2024
Table 16: Clinical Trials in OTC Drugs, Medical Devices, and Diagnostics, by Phase, October 2024
Table 17: OTC Drugs, Medical Devices and Diagnostics Inclusion, by Product
Table 18: Global Market for OTC Drugs, Medical Devices and Diagnostics, by Product, Through 2029
Table 19: Global Market for OTC Drugs, by Region, Through 2029
Table 20: Global Market for OTC Drugs, by Type, Through 2029
Table 21: Most Common OTC Cough, Cold and Respiratory Drugs
Table 22: Most Common OTC Analgesic/Antipyretic
Table 23: Most Common OTC Gastrointestinal Drugs
Table 24: Most Common OTC Dermatological Drugs
Table 25: Key Marketed OTC Pharmaceutical Drugs, by Company
Table 26: Global Market for Pharmaceutical Drugs, by Region, Through 2029
Table 27: Key Marketed Vitamin and Mineral Supplements, by Company
Table 28: Global Market for Vitamin and Mineral Supplements, by Region, Through 2029
Table 29: Global Market for OTC Devices and Diagnostics, by Region, Through 2029
Table 30: Global Market for OTC Devices and Diagnostics, by Type, Through 2029
Table 31: OTC Cardiac Monitoring Devices, by Company
Table 32: OTC Blood Pressure Monitoring Devices, by Company
Table 33: OTC Pulse Oximeter, by Company
Table 34: OTC Glucose Monitoring Devices, by Company
Table 35: OTC Sleep Monitoring Devices, by Company
Table 36: Fetal Monitoring Devices, by Company
Table 37: Global Market for Monitoring Devices, by Region, Through 2029
Table 38: Pain Management Devices, by Company
Table 39: Rehabilitation Devices, by Company
Table 40: Other OTC Devices, by Company
Table 41: Global Market for Therapeutic Devices, by Region, Through 2029
Table 42: Diagnostic Devices and Kits, by Company
Table 43: Global Market for Diagnostic Devices and Kits, by Region, Through 2029
Table 44: Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Application, Through 2029
Table 45: Global Market for Respiratory Disorders, by Region, Through 2029
Table 46: Gastrointestinal Disorders: OTC Drug Management
Table 47: Global Market for Gastrointestinal Disorders, by Region, Through 2029
Table 48: Global Market for Orthopedic Diseases, by Region, Through 2029
Table 49: Global Market for Cardiovascular Diseases, by Region, Through 2029
Table 50: Worldwide Diabetes Estimates (20-79 Years), by Region, 2021-2045
Table 51: Global Market for Diabetes, by Region, Through 2029
Table 52: Global Market for Skin Disorders, by Region, Through 2029
Table 53: Global Market for Obesity, by Region, Through 2029
Table 54: Global Market for ENT Disorders, by Region, Through 2029
Table 55: Global Market for Sleep Disorders, by Region, Through 2029
Table 56: Global Market for Other Disorders, by Region, Through 2029
Table 57: Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Region, Through 2029
Table 58: North American Market for OTC Drugs, Medical Devices, and Diagnostics, by Country, Through 2029
Table 59: European Market for OTC Drugs, Medical Devices, and Diagnostics, by Country, Through 2029
Table 60: Asia-Pacific Market for OTC Drugs, Medical Devices, and Diagnostics, by Country, Through 2029
Table 61: OTC Pharmaceutical Drugs: Market Player Share Analysis, 2023
Table 62: OTC Drugs, Medical Devices, and Diagnostics: Recent Strategic Developments, 2022-2024
Table 63: ESG Rankings for OTC Drug, Medical Device, and Diagnostics Companies, 2024*
Table 64: ESG: Environmental Overview
Table 65: ESG: Social Overview
Table 66: ESG: Governance Overview
Table 67: Report Specific Information Sources
Table 68: Abbreviations Used in OTC Drugs, Medical Devices, and Diagnostics Market
Table 69: Abbott: Company Snapshot
Table 70: Abbott: Financial Performance, FY 2022 and 2023
Table 71: Abbott: Product Portfolio
Table 72: Abbott: News/Key Developments, 2021-2024
Table 73: Bayer AG: Company Snapshot
Table 74: Bayer AG: Financial Performance, FY 2022 and 2023
Table 75: Bayer AG: Product Portfolio
Table 76: DSM-Firmenich: Company Snapshot
Table 77: DSM-Firmenich: Financial Performance, FY 2022 and 2023
Table 78: DSM-Firmenich: Product Portfolio
Table 79: DSM-Firmenich: News/Key Developments, 2023
Table 80: Haleon Group of Co.: Company Snapshot
Table 81: Haleon Group of Co.: Financial Performance, FY 2022 and 2023
Table 82: Haleon Group of Co.: Product Portfolio
Table 83: Haleon Group of Co.: News/Key Developments, 2023 and 2024
Table 84: Kenvue: Company Snapshot
Table 85: Kenvue: Financial Performance, FY 2022 and 2023
Table 86: Kenvue: Product Portfolio
Table 87: Koninklijke Philips N.V.: Company Snapshot
Table 88: Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 89: Koninklijke Philips N.V.: Product Portfolio
Table 90: Masimo: Company Snapshot
Table 91: Masimo: Financial Performance, FY 2022 and 2023
Table 92: Masimo: Product Portfolio
Table 93: Masimo: News/Key Developments, 2024
Table 94: Nestle: Company Snapshot
Table 95: Nestle: Financial Performance, FY 2022 and 2023
Table 96: Nestle: Product Portfolio
Table 97: Nestle: News/Key Developments, 2024
Table 98: Procter & Gamble: Company Snapshot
Table 99: Procter & Gamble: Financial Performance, FY 2022 and 2023
Table 100: Procter & Gamble: Product Portfolio
Table 101: Sanofi: Company Snapshot
Table 102: Sanofi: Financial Performance, FY 2022 and 2023
Table 103: Sanofi: Product Portfolio
Table 104: Sanofi: News/Key Developments, 2023 and 2024
List of Figures
Summary Figure: Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Product, 2021-2029
Figure 1: Advantages and Disadvantages of OTC Drugs, Medical Devices, and Diagnostics
Figure 2: OTC Drugs, Medical Devices, and Diagnostics: PESTLE Analysis
Figure 3: Market Dynamics of OTC Drugs, Medical Devices, and Diagnostics
Figure 4: Global Population Share Above 65 Years, 2019-2023
Figure 5: Security Risk of Wearable
Figure 6: Emerging Trends/Technologies in the OTC Drugs, Medical Device and Diagnostics Market
Figure 7: Global Market Shares for OTC Drugs, Medical Devices and Diagnostics, by Product, 2023
Figure 8: Global Market Shares for OTC Drugs, by Type, 2023
Figure 9: Global Market Shares for OTC Devices and Diagnostics, by Type, 2023
Figure 10: Global Market Shares for OTC Drugs, Medical Devices, and Diagnostics, by Application, 2023
Figure 11: Percentage of Population Aged 65 Years and Above, by Region, 2050
Figure 12: Worldwide Diabetes Estimates (20-79 Years), by Region, 2021, 2030 and 2045
Figure 13: Global Market Shares for OTC Drugs, Medical Devices, and Diagnostics, by Region, 2023
Figure 14: North American Market Shares of OTC Drugs, Medical Devices, and Diagnostics, by Country, 2023
Figure 15: U.S. Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 16: Canadian Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 17: European Market Shares of OTC Drugs, Medical Devices, and Diagnostics, by Country, 2023
Figure 18: German Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 19: U.K. Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 20: French Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 21: Italian Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 22: Rest of European Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 23: Asia-Pacific Market Shares of OTC Drugs, Medical Devices, and Diagnostics, by Country, 2023
Figure 24: Chinese Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 25: Indian Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 26: Japanese Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 27: Rest of Asia-Pacific Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 28: Rest of the World Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 29: Major Vitamin and Mineral Supplements Players
Figure 30: Major OTC Medical Device Players
Figure 31: ESG Pillars
Figure 32: Advantages of ESG for Companies
Figure 33: Key ESG Issues in the OTC Drug, Medical Device, and Diagnostics Industry
Figure 34: Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 35: Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 36: Bayer AG: Revenue Shares, by Business Unit, FY 2023
Figure 37: Bayer AG: Revenue Shares, by Country/Region, FY 2023
Figure 38: DSM-Firmenich: Revenue Shares, by Business Unit, FY 2023
Figure 39: DSM-Firmenich: Revenue Shares, by Country/Region, FY 2023
Figure 40: Haleon Group of Co.: Revenue Shares, by Business Unit, FY 2023
Figure 41: Haleon Group of Co.: Revenue Shares, by Country/Region, FY 2023
Figure 42: Kenvue: Revenue Shares, by Business Unit, FY 2023
Figure 43: Kenvue: Revenue Shares, by Country/Region, FY 2023
Figure 44: Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2023
Figure 45: Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2023
Figure 46: Masimo: Revenue Shares, by Business Unit, FY 2023
Figure 47: Masimo: Revenue Shares, by Country/Region, FY 2023
Figure 48: Nestle: Revenue Shares, by Business Unit, FY 2023
Figure 49: Nestle: Revenue Shares, by Country/Region, FY 2023
Figure 50: Procter & Gamble: Revenue Shares, by Business Unit, FY 2023
Figure 51: Procter & Gamble: Revenue Shares, by Country/Region, FY 2023
Figure 52: Sanofi: Revenue Shares, by Business Unit, FY 2023
Figure 53: Sanofi: Revenue Shares, by Country/ Region, FY 2023
